title: Chronic pyelonephritis: modulation of host defenses by cyclosporin A.
abstract: Chronic experimental pyelonephritis is characterized by a stable level of infection, which persists for many months. Administration of cyclosporin A (CsA) reactivated previously healed renal lesions and caused a marked increase in bacterial numbers in the kidney. Studies were then carried out to compare the effects of CsA, and the nonselective cytodepletive agents irradiation and cyclophosphamide, on both host defenses and the bacteriologic status of chronically infected kidneys. Two different responses were observed. In animals treated with CsA, bacterial numbers increased markedly, although circulating neutrophil numbers were relatively unaffected. This observation was in contrast to the severe ablation of leukocyte numbers and competence needed to achieve an equivalent effect when irradiation and cyclophosphamide were used. One possible explanation for the adverse effect of CsA on the host-parasite balance in chronic pyelonephritis is that CsA affects mediators that control the inflammatory response or induces a qualitative change in a critical cellular defense compartment.
authors.affiliation: Department of Medicine, Auckland Hospital, New Zealand.
authors.forename: G
authors.initials: G
authors.lastname: Findon
authors.forename: T E
authors.initials: TE
authors.lastname: Miller
mesh_terms: D000818:Animals; D003520:Cyclophosphamide / Q000494:pharmacology; D003524:Cyclosporins / Q000494:pharmacology*; D004926:Escherichia coli / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000276:immunology* / Q000382:microbiology / Q000473:pathology; D005260:Female; D007668:Kidney / Q000382:microbiology* / Q000473:pathology / Q000528:radiation effects; D007958:Leukocyte Count; D007962:Leukocytes / Q000473:pathology; D008297:Male; D009504:Neutrophils / Q000473:pathology; D011704:Pyelonephritis / Q000276:immunology* / Q000382:microbiology / Q000473:pathology; D051381:Rats
chemical_list: D003524:Cyclosporins; D003520:Cyclophosphamide